Frédérique Maindrault‐Gœbel

Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study

Benoist Chibaudel, Frédérique Maindrault‐Gœbel, Gérard Lledo et al. · Journal of Clinical Oncology · 2009 · 396 citations

Medicine, Oncology, Pharmacotherapy +14

Allergic-type reactions to oxaliplatin: Retrospective analysis of 42 patients

Frédérique Maindrault‐Gœbel, Thierry André, Christophe Tournigand et al. · European Journal of Cancer · 2005 · 126 citations

Life Sciences, Immunology, Oncology +14

Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients

Marie-Christine Étienne-Grimaldi, G. Milano, Frédérique Maindrault‐Gœbel et al. · British Journal of Clinical Pharmacology · 2009 · 96 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Platinum-sensitivity in metastatic colorectal cancer: Towards a definition

Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain et al. · European Journal of Cancer · 2013 · 57 citations

Medicine, Cancer Biology, Oncology +12

<scp>PEPCOL</scp>: a <scp>GERCOR</scp> randomized phase <scp>II</scp> study of nanoliposomal irinotecan <scp>PEP</scp>02 (<scp>MM</scp>‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer

Benoist Chibaudel, Frédérique Maindrault‐Gœbel, Jean‐Baptiste Bachet et al. · Cancer Medicine · 2016 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17